DRICH1: A Protein with Potential as A Drug Target Or Biomarker

Target Name: DRICH1

NCBI ID: G51233

DRICH1

DRICH1: A Protein with Potential as A Drug Target Or Biomarker

DRICH1 (Aspartate rich 1) is a protein that is expressed in various tissues and cells throughout the body. Its primary function is to regulate the structure and function of DNA in cells. It is a key player in the regulation of gene expression and has been implicated in a number of cellular processes, including cell division, apoptosis, and DNA damage repair. As a result, DRICH1 has potential as a drug target or biomarker in a variety of diseases.

DRICH1 was first identified in the late 1990s as a highly conserved protein that is expressed in a wide range of tissues, including muscle, liver, and brain. It is characterized by a unique N-terminus that consists of 21 amino acids, as well as a C-terminus that is rich in Asparagine residues. The Asparagine residues are important for the protein's stability and can interact with a variety of molecules, including other proteins and nucleic acids.

One of the key functions of DRICH1 is its role in regulating gene expression. It is well established that DRICH1 plays a role in the regulation of gene expression by binding to specific DNA sequences and affecting the activity of transcription factors. For example, studies have shown that DRICH1 can interact with the transcription factor, p53, and that this interaction can modulate the activity of the p53 gene. In addition, DRICH1 has been shown to play a role in the regulation of microRNA (miRNA) expression, which are small non-coding RNAs that play important roles in post-transcriptional gene regulation.

DRICH1's role in regulating DNA damage repair is another potential drug target or biomarker. DNA damage repair is a critical process that helps cells maintain the integrity of their genetic material and prevent the development of diseases such as cancer. DRICH1 has been shown to play a role in the regulation of DNA damage repair by binding to specific DNA repair factors and affecting their activity. This interaction between DRICH1 and DNA repair factors could make it a potential target for drugs that are designed to inhibit DNA damage repair in cancer cells.

In addition to its role in regulating gene expression and DNA damage repair, DRICH1 has also been shown to play a role in the regulation of cell division. It is well established that DRICH1 is involved in the regulation of cell division by binding to the protein, cyclin D1 (CDK1), and affecting its activity. This interaction between DRICH1 and CDK1 could make DRICH1 a potential target for drugs that are designed to inhibit cell division in cancer cells.

Overall, DRICH1 is a protein that has the potential to be a drug target or biomarker in a variety of diseases. Its unique structure and function, as well as its involvement in the regulation of gene expression, DNA damage repair, and cell division, make it an attractive target for the development of new therapies. While further research is needed to fully understand its role in these processes, its potential as a drug target or biomarker is significant.

Protein Name: Aspartate Rich 1

The "DRICH1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DRICH1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets